Suzanne D. Conzen, M.D., is a Professor in the Department of Internal Medicine and Chief of the Division of Hematology and Oncology at the University of Texas Southwestern Medical Center. Dr. Conzen earned her medical degree from the Yale School of Medicine, an MSc from the London School of Hygiene and Tropical Medicine, and completed her residency in internal medicine at New York Hospital-Cornell Medical Center. She received advanced training in hematology and medical oncology during a clinical fellowship at Dartmouth-Hitchcock Medical Center and in molecular oncology through a Howard Hughes Research Institute postdoctoral fellowship at Dartmouth Medical School. Dr. Conzen then spent the next 20 years as an NIH-funded Physician Scientist and breast cancer medical oncologist at The University of Chicago.

Read More

Suzanne D. Conzen, M.D., is a Professor in the Department of Internal Medicine and Chief of the Division of Hematology and Oncology at the University of Texas Southwestern Medical Center. Dr. Conzen earned her medical degree from the Yale School of Medicine, an MSc from the London School of Hygiene and Tropical Medicine, and completed her residency in internal medicine at New York Hospital-Cornell Medical Center. She received advanced training in hematology and medical oncology during a clinical fellowship at Dartmouth-Hitchcock Medical Center and in molecular oncology through a Howard Hughes Research Institute postdoctoral fellowship at Dartmouth Medical School. Dr. Conzen then spent the next 20 years as an NIH-funded Physician Scientist and breast cancer medical oncologist at The University of Chicago.

In 2019 she was recruited to UT Southwestern as a CPRIT Established Investigator and Chief of the Division of Hematology and Oncology. Dr Conzen’s research at The University of Chicago led to the recognition that glucocorticoid receptor plays a key role in epithelial cancers, and that GR modulation in breast cancer, and more recently, in prostate and ovarian cancers, allows rewiring of pro-oncogenic transcriptional networks. Dr. Conzen’s laboratory also receives peer-reviewed funding from the Breast Cancer Research Foundation and the National Institutes of Health. She has served as a senior editor of Cancer Research and as Chair of the National Institutes of Health’s Cancer Etiology Study Section. She is an elected member of the American Society for Clinical Investigation and in 2019, was inducted into the American Association of Physicians.

Read Less